3R Study (ready to reduce risk)

Not Applicable

Completed

• Conditions: Specialty: Cardiovascular disease, Primary sub-specialty: UKCRC code/ Disease: Circulatory System; Cardiovascular disease

• Registration Number: ISRCTN16863160
• Lead Sponsor: niversity of Leicester

Brief Summary

2018 results in https://www.ncbi.nlm.nih.gov/pubmed/30425027 2020 results in https://pubmed.ncbi.nlm.nih.gov/32713349/ (added 28/07/2020)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-04-26
• Study Completion: 2018-12-31
• Last Update Posted: 10 August 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 212

Inclusion Criteria

1. Aged 40­-74 years old inclusive
2. Prescribed statin medication for primary prevention of CVD that is still active, at least 12 months prior to enrolment
3. TC level =5.0 mmols/L at enrolment
4. Ability to speak and read English to participate effectively in the group education programme
5. Willing and able to attend the education sessions and clinic visits
6. Willing and able to give informed consent
7. Willing to allow GP to be notified of participation in the study, so access post­consent to relevant medical records can be obtained
8. Have access to a mobile phone to receive text messages

Exclusion Criteria

1. Under 40 years of age and 75 years and over
2. Unable or unwilling to give informed consent
3. Pre­existing CVD
4. Total cholesterol < 5 mmol/l
5. Inherited lipid disorder
6. Established Type 1 or Type 2 diabetes
7. Females who are pregnant (self ­reported)
8. Currently participating or participated in another clinical intervention study in the past 12 weeks

Study & Design

• Study Type: Interventional
• Study Design: Not specified